With 0.93 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.04 million shares. The 52-week range on ENOV shows that it touched its highest point at $51.10 and its lowest point at $29.32 during that stretch. It currently has a 1-year price target of $56.50. Beta for the stock currently stands at 1.54.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ENOV was down-trending over the past week, with a drop of -9.40%, but this was down by -4.20% over a month. Three-month performance dropped to -24.21% while six-month performance fell -28.92%. The stock lost -36.72% in the past year, while it has lost -26.23% so far this year. A look at the trailing 12-month EPS for ENOV yields -14.48 with Next year EPS estimates of 3.42. For the next quarter, that number is 0.72. This implies an EPS growth rate of 6.58% for this year and 12.83% for next year. EPS is expected to grow by 11.76% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -4.65%.
Float and Shares Shorts:
At present, 57.12 million ENOV shares are outstanding with a float of 55.97 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ENOV since 4 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $2.78995 being high and $2.77003 being low. For ENOV, this leads to a yearly average estimate of $2.77999. Based on analyst estimates, the high estimate for the next quarter is $0.78 and the low estimate is $0.59. The average estimate for the next quarter is thus $0.66.
